THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Jan. 21, 2005--Amgen Inc.
(Nasdaq:AMGN), the world´s largest biotechnology company, today
announced that it plans to report its 2004 fourth quarter and full
year financial results on Thursday, January 27, 2005 before the
opening of the financial markets. The announcement will be followed by
a live conference with the investment community at 8 a.m. Eastern
Participating in the event from Amgen will be Kevin Sharer,
chairman and chief executive officer, and other members of Amgen´s
senior management team.
The conference will be simultaneously broadcast over the Internet
and will be available to members of the news media, investors and the
general public. The event, including the question and answer session,
is expected to last approximately two hours.
The webcast of the conference can be found on Amgen´s Web site,
www.amgen.com, by clicking on Investors. A link to the webcast is
under the Events header. The webcast will be archived and available
for replay 72 hours after the event.
Amgen is a global biotechnology company that discovers, develops,
manufactures and markets important human therapeutics based on
advances in cellular and molecular biology.
CONTACT: Amgen, Thousand Oaks
Christine Cassiano, 805-447-4587 (media)
Arvind Sood, 805-447-1060 (investors)